Julie Traclet

Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study)

Mouhamad Nasser, Sophie Larrieu, Salim Si‐Mohamed et al. · European Respiratory Journal · 2020 · 218 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension

Athénaïs Boucly, Vincent Cottin, Hilario Nunès et al. · European Respiratory Journal · 2017 · 151 citations · Full text

Medicine, Cardiology, Hemodynamic Management +13

The Aggregate Index of Systemic Inflammation (AISI): A Novel Prognostic Biomarker in Idiopathic Pulmonary Fibrosis

Angelo Zinellu, Claudia Collu, Mouhamad Nasser et al. · Journal of Clinical Medicine · 2021 · 131 citations · Full text

Medicine, Immunology, Pathology +15

Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial

Julie Mankikian, Agnès Caille, Martine Reynaud‐Gaubert et al. · European Respiratory Journal · 2023 · 121 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +13

Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension

Jason Weatherald, Athénaïs Boucly, David Launay et al. · European Respiratory Journal · 2018 · 89 citations · Full text

Medicine, Cardiology, Clinical Cardiology +16